Predicting the response to anti-PD1 therapy in metastatic melanoma

被引：4
|
作者：
Heinzerling, Lucie [1 ]
Kirchberger, Michael Constantin [1 ]
Walter, Lisa [1 ]
Schuler, Gerold [1 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Bavaria, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
PD-1; BLOCKADE; UNTREATED MELANOMA; CTLA-4; CANCER; RESISTANCE; IPILIMUMAB; PEMBROLIZUMAB; SENSITIVITY; EXPRESSION; NIVOLUMAB;
D O I：
10.21037/tcr.2016.09.40
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S576 / S579
页数：4
相关论文
共 50 条
  • [1] Predicting the anti-PD1 response
    Minton, Kirsty
    [J]. NATURE REVIEWS IMMUNOLOGY, 2019, 19 (07) : 414 - 415
  • [2] PERFORMANCE STATUS AS A PREDICTOR OF RESPONSE TO ANTI-PD1 FOR METASTATIC MELANOMA
    Wong, A.
    Williams, M.
    Milne, D.
    Morris, K.
    Lau, P.
    Spruyt, O.
    Fullerton, S.
    McArthur, G.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 71 - 71
  • [3] Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma
    Tumeh, Paul Camille
    Rosenblum, Michael
    Handley, Nathan
    Tsai, Katy
    Rodriguez, Robert S. Rodriguez
    Khurana, Niharika
    Harview, Christina
    Spasic, Marko
    Sanchez, Phillip J.
    Chang, Jeremy
    Shintaku, I. Peter
    Taylor, Emma
    Chmielowski, Bartosz
    Grogan, Tristan
    Elashoff, David A.
    Pierce, Robert H.
    Daud, Adil
    [J]. CANCER RESEARCH, 2015, 75
  • [4] Predicting the anti-PD1 response
    Kirsty Minton
    [J]. Nature Reviews Immunology, 2019, 19 : 414 - 415
  • [5] Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
    Paoluzzi, L.
    Cacavio, A.
    Ghesani, M.
    Karambelkar, A.
    Rapkiewicz, A.
    Weber, J.
    Rosen, G.
    [J]. CLINICAL SARCOMA RESEARCH, 2016, 6
  • [6] Response to anti-PD1/PDL1 therapy in patients with metastatic desmoplastic melanoma.
    Eroglu, Zeynep
    Kim, Dae Won
    Johnson, Douglas Buckner
    Algazi, Alain Patrick
    Munhoz, Rodrigo Ramella
    Liniker, Elizabeth
    Kong, Ben
    Khurana, Neharika
    Chmielowski, Bartosz
    Sosman, Jeffrey Alan
    Scolyer, Richard A.
    Carlino, Matteo S.
    Postow, Michael Andrew
    Hwu, Wen-Jen
    Long, Georgina V.
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Artificial Intelligence Estimates the Importance of Baseline Factors in Predicting Response to Anti-PD1 in Metastatic Melanoma
    Indini, Alice
    Di Guardo, Lorenza
    Cimminiello, Carolina
    De Braud, Filippo
    Del Vecchio, Michele
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (08): : 643 - 648
  • [8] ANTI-PD1 THERAPY IN PATIENTS WITH METASTATIC MELANOMA: A SINGLE CENTRE EXPERIENCE
    Nguyen, B.
    Robinson, E.
    Arora, A.
    Sayed, A.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 65 - 65
  • [9] Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma
    Roncati, Luca
    [J]. ACTA DERMATOVENEROLOGICA CROATICA, 2018, 26 (04) : 341 - 343
  • [10] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    [J]. MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
12345